Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-75,218
Closed -$805K 499
2016
Q4
$805K Sell
75,218
-282
-0.4% -$2.96K 0.01% 536
2016
Q3
$830K Sell
75,500
-160
-0.2% -$1.87K 0.01% 523
2016
Q2
$797K Hold
75,660
0.01% 532
2016
Q1
$953K Sell
75,660
-8,660
-10% -$95K 0.01% 495
2015
Q4
$889K Sell
84,320
-409,972
-83% -$3.77M 0.01% 530
2015
Q3
$3.55M Buy
494,292
+52,430
+12% +$713K 0.03% 229
2015
Q2
$7.99M Buy
441,862
+50,632
+13% +$870K 0.05% 186
2015
Q1
$6.15M Buy
391,230
+187,309
+92% +$2.83M 0.03% 348
2014
Q4
$2.88M Buy
203,921
+190,857
+1,461% +$2.87M 0.01% 540
2014
Q3
$223K Sell
13,064
-39
-0.3% -$896 ﹤0.01% 722
2014
Q2
$391K Sell
13,103
-5,192
-28% -$125K ﹤0.01% 717
2014
Q1
$456K Sell
18,295
-103,205
-85% -$3.02M ﹤0.01% 725
2013
Q4
$3.49M Sell
121,500
-9,490
-7% -$278K 0.01% 584
2013
Q3
$4.32M Sell
130,990
-218,488
-63% -$6.79M 0.02% 527
2013
Q2
$10.8M Buy
+349,478
New +$9.38M 0.05% 285

Other funds holding INVA

TCW Group's INVA Position: Q1 2017 in Review

TCW Group sold out of Innoviva (INVA) in Q1 2017, closing a stake of 75,218 shares — an estimated $805K sold.

TCW Group first reported a position in INVA in Q2 2013 and held it in 15 quarters. The position peaked at $10.8M in Q2 2013. 164 funds tracked by Wall St. Rank hold INVA as of Q1 2017.

  • TCW Group reported no remaining Innoviva position as of Q1 2017 after selling out during the quarter.
  • TCW Group sold 75,218 Innoviva shares in Q1 2017, an estimated $805K.
  • TCW Group first reported a position in Innoviva in Q2 2013 and held it in 15 quarters.
  • TCW Group's Innoviva position peaked at $10.8M in Q2 2013.
  • 164 funds tracked by Wall St. Rank held Innoviva as of Q1 2017.

Based on TCW Group's 13F filing for Q1 2017, filed 12 May 2017.